Provided by Tiger Trade Technology Pte. Ltd.

Vir Biotechnology, Inc.

11.29
+0.11000.98%
Post-market: 11.500.2100+1.86%19:30 EDT
Volume:2.58M
Turnover:29.23M
Market Cap:1.90B
PE:-6.65
High:11.61
Open:10.86
Low:10.86
Close:11.18
52wk High:11.94
52wk Low:4.82
Shares:168.65M
Float Shares:130.00M
Volume Ratio:1.63
T/O Rate:1.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6972
EPS(LYR):-3.1619
ROE:-26.08%
ROA:-14.51%
PB:1.94
PE(LYR):-3.57

Loading ...

Vir Biotechnology Names Brent Sabatini Interim Principal Financial Officer as CFO Exits

Reuters
·
Jul 24

Vir Biotechnology - Appoints Brent Sabatini as Interim Principal Financial Officer Effective July 23

THOMSON REUTERS
·
Jul 24

Vir Biotechnology - Jason O’byrne to Leave Vir Biotechnology, Remains Through August 3 for Transition

THOMSON REUTERS
·
Jul 24

Vir Biotechnology Announces Chief Financial Officer Transition

THOMSON REUTERS
·
Jul 24

Vir Biotechnology Schedules Conference Call on Second-quarter 2026 Results

Reuters
·
Jul 23

Brii Biosciences Says Arbitration with Vir Clouds Future of Elebsiran Program

Reuters
·
Jul 03

Is Vir Biotechnology (VIR) Quietly Recasting Its Governance Strength With a New Audit Committee Chair?

Simply Wall St.
·
Jun 18

Vir Biotechnology Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jun 11

Vir Biotechnology Inc : Morgan Stanley Raises Target Price to $27.00 From $23.00

THOMSON REUTERS
·
Jun 11

Vir Biotechnology names Timothy Coughlin to board, taps him as audit committee chair

Reuters
·
Jun 11

Vir Biotechnology Announces Appointment of Timothy Coughlin to Its Board of Directors

THOMSON REUTERS
·
Jun 11

Vir Biotechnology Is Maintained at Outperform by Leerink Partners

Dow Jones
·
Jun 03

Vir director Janet Napolitano disposes of 3,200 Vir Biotechnology shares for $30,240

Reuters
·
Jun 03

Vir Biotechnology SVP, Chief Accounting Officer Brent Sabatini sells 379 shares for $3,581.55

Reuters
·
Jun 03

H.C. Wainwright Sticks to Their Buy Rating for Vir Biotechnology (VIR)

TIPRANKS
·
May 28

Vir Biotechnology shareholders elect three directors at annual meeting

Reuters
·
May 28

Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), GeoVax Labs (GOVX) and Vir Biotechnology (VIR)

TIPRANKS
·
May 27

Assessing Vir Biotechnology (VIR) Valuation After Hepatitis Delta Data Update And Astellas Oncology Partnership

Simply Wall St.
·
May 25

Brii Biosciences says arbitration with Vir clouds elebsiran hepatitis B program future

Reuters
·
May 22

Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR), MoonLake Immunotherapeutics (MLTX) and Dogwood Therapeutics (DWTX)

TIPRANKS
·
May 20